Topic

Peripheral Arterial Disease


SIR: Drug-eluting stents emerge as option for critical limb ischemia

Conference News | Tuesday, March 16 2010
Interventional radiologists have found that a subgroup of patients with critical limb ischemia, the most severe form of peripheral arterial disease (PAD), may avoid amputation through the use of drug-eluting stents on the smaller arteries below the knee, according to a study released at this week’s Society of Interventional Radiology's (SIR) Annual Scientific Meeting in Tampa, Fla.
 

SIR: Microbubbles with stem cells can stimulate new blood vessels in the leg

Conference News | Monday, March 15 2010
Bone marrow stem cells suspended in X-ray-visible microbubbles can help in treating peripheral arterial disease (PAD) patients by increasing the number of blood vessels, according to research presented at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla. this week.
 

SIR: ABI testing can better predict those at risk for coronary disease

Conference News | Friday, March 12 2010
Testing patients for peripheral arterial disease (PAD) via abnormal ankle brachial index (ABI) exams can identify patients at risk for future cardiac events who were not considered in the high-risk category with Framingham risk assessments, according to results of a clinical trial presented at the 35th annual scientific meeting of the Society of Interventional Radiology's in Tampa, Fla.
 

JACC: Pre-op coronary angiography more effective in long term

Clinical Studies | Tuesday, September 15 2009
A strategy of systematic coronary angiography can positively impact the long-term outcome of peripheral arterial disease surgical patients at medium to high risk, according to a study in the Sept. 8 issue of the Journal of the American College of Cardiology.
 

Siemens becomes Volcano IVUS/FFR reseller

Partnerships & Alliances | Tuesday, August 25 2009
Volcano, a developer of products for the diagnosis of coronary and peripheral artery disease, has entered into a non-exclusive, global resale agreement with Siemens Healthcare.
 

Cook, Angiotech peripheral DES gains CE Mark

Regulatory News | Tuesday, August 11 2009
Cook Medical and Angiotech Pharmaceuticals received CE Mark approval Monday for their polymer-free Zilver PTX drug-eluting peripheral stent to treat blockages in the legs caused by peripheral arterial disease.
 

SIR: Adult stem cells may be viable for PAD therapy

Conference News | Wednesday, March 11 2009
Interventional radiologists are establishing how to use stem cells to create new or more blood vessels to treat peripheral arterial disease (PAD) in individuals with extensively narrowed or clogged arteries. Recent successful techniques use imaging to view and locate transplanted stem cells, and to confirm that they remain alive in the body once injected, according to a study presented at the Society of Interventional Radiology (SIR) annual conference this week in San Diego.
 

SIR: Interventional rads save limbs with drug-eluting stents

Conference News | Tuesday, March 10 2009
Treating critical limb ischemia in peripheral arterial disease (PAD) patients with below-the-knee angioplasty is thwarted by restenosis, the need for repeat treatments and the continued progression of atherosclerotic disease, leading to tissue death and amputation. However, interventional radiologists have found that drug-eluting stents (DES) lessen the rate of repeat procedures to open these small arteries, according to results presented at the Society of Interventional Radiology (SIR) annual meeting in San Diego this week.
 

SIR: Ankle brachial index IDs heart risk missed by Framingham score

Conference News | Tuesday, March 10 2009
The use of common screening tests like the ankle brachial index (ABI), along with traditional risk scoring systems, such as the Framingham Risk Score (FRS), could prevent thousands of MIs in individuals who were not originally thought to be at high risk, according to findings presented at the 2009 meeting of the Society of Interventional Radiology (SIR) in San Diego this week.
 
Web Exclusives

Feature: U.S. needs national strategy to curb imaging overutilization

Medical imaging overutilization--a growing concern in the U.S.--exposes patients to unnecessary radiation, while also adding to rising healthcare costs, according to a study published online Aug. 24 in Radiology. In an interview, William R. Hendee, PhD, lead author, reviewed various methods by which medical imaging could be curtailed.

Radiology: Prelim study shows CE breast CT outperforms CT, mammo

Dedicated contrast-enhanced (CE) breast CT delivered significantly improved conspicuity of malignant breast lesions, including ductal carcinoma in situ (DCIS), compared with unenhanced breast CT and mammography, according to a study published in the September issue of Radiology.

Radiology: Rad role may evolve as image-guided biopsies trend up

CT, ultrasound and MRI have helped shift biopsy techniques away from more invasive approaches toward image-guided percutaneous techniques, according to a study published in the September issue of Radiology. The trend toward less-invasive approaches translates into enhanced safety and efficiency and could lead to more interaction between patients and radiologists.

CMS Webinar: Incentive payments to offset EHR adoption, not reimburse

The Centers for Medicare & Medicaid Services’ (CMS) EHR incentive payments are not considered reimbursement for money expended on EHR technology, but are intended to offset the cost associated with adoption and ongoing meaningful use, according to CMS during an Aug. 12 webinar.

CMS webinar: Eligible professionals can expect EHR incentives in 2011

Funding incentives for EHR use is the main goal of the Centers for Medicare & Medicaid Services' (CMS) meaningful use initiative, and there are incentive programs for both hospitals and eligible professionals, according to Elizabeth Holland, health insurance specialist at the Department of Health and Human Services, who spoke during a CMS-sponsored webinar Aug. 8.

Webinar: Stage 1 of meaningful use is for quality reporting acclimation

Stage 1 requirements for meaningful use incentives aim to strike a balance between the overall goal of EHR use and widespread adoption, while avoiding added work, said Jonathan Teich, MD, PhD, chief medical informatics officer at Elsevier Health Services, during a HIMSS webinar titled “Meaningful Use: Safety and Quality of Care.”

PORTALS

Advanced Visualization

Molecular Imaging

Integration Tools & Interoperability

More Portal Topics